公司資料
Bellerophon Therapeutics 股價、新聞與催化劑
- 股票代碼:
- BLPH
- 交易所:
- PINK
- 產業:
- Biopharma
- 所在地:
- United States
股價為何變動
Current closing-price context is not available for BLPH.
公司概覽
業務概覽
Bellerophon Therapeutics was a pulmonary-hypertension company focused on inhaled nitric-oxide and cardiopulmonary science before its restructuring and public-market decline. Its platform targeted severe lung disease.
所在地與產業分類
Headquartered in the United States and listed on NASDAQ before restructuring, Bellerophon sat in specialty biotechnology.
商業模式特徵
The business depended on clinical validation, delivery science, and the ability to commercialize a focused respiratory platform.
生技產業定位
Bellerophon belongs to the historical respiratory-biotech set rather than the current live public-company set.
未來催化劑
- Bellerophon Therapeutics’s catalysts are INOpulse-related updates and any strategic move that clarifies the company’s future. The market is mostly waiting to see whether there is still a viable commercial or asset path.
近期新聞
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。